LLY

#12
Eli Lilly & Co.
905.03 USD
-1.95%
Sektor: Gesundheitswesen
Basis: USD
Gewinnwährung: USD
Tagesspanne
902.81
909.45
Jahresspanne
644.51
1 133.95
Tagesänderung
-1.95%
Monatliche Änderung
-7.64%
6 month change
+14.82%
Jahresänderung
+7.54%
Vorheriger Schlusskurs
923.03
Eröffnung
903.82
Bid
Ask
Tief
902.81
High
909.45
Volumen
3 446
Vollständige Grafik anzeigen

Financials

Übersicht Finanzbericht Statistik Dividenden
Vierteljährlich Jährlich
  • Market Capitalization 853.77 B
  • Employee 50 K
  • Founded N/A
  • CEO David A. Ricks
  • Website www.lilly.com
  • Headquarter Indiana, United States
  • FIGI BBG000BNBDC2
  • Industry Arzneimittelhersteller – allgemein
Gesamtumsatz
Jahresüberschuss
Unverwässertes Ergebnis je Aktie (Unverwässertes EPS)
Gesamtverschuldung
Freier Cashflow
Zahlungsmittel und Zahlungsmitteläquivalente
Kurs-Gewinn-Verhältnis
46.83
Preis-Umsatz-Verhältnis
14.83
Dividende je Aktie
6.23
Dividendenrendite in %
0.58

Eli Lilly and Company

Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by Eli Lilly, a pharmaceutical chemist and Union army veteran during the American Civil War for whom the company was later named. The company is ranked 4th on the list of largest biomedical companies by revenue and is the most valuable pharmaceutical company worldwide. It is ranked 100th on the Fortune 500 and 138th on the Forbes Global 2000. In November 2025, the company reached a $1 trillion market capitalization, the first health-care company in the world to do so.

Nachrichten